Search

Search Constraints

You searched for: Author/Creator Hatakeyama, Shingo

Search Results

11. Avelumab plus axitinib vs sunitinib for advanced renal cell carcinoma: Japanese subgroup analysis from JAVELIN Renal 101. Issue 3 (5th February 2020)

13. Cancer‐specific and net overall survival in older patients with de novo metastatic prostate cancer initially treated with androgen deprivation therapy. (25th May 2022)

14. Changes in conditional net survival and dynamic prognostic factors in patients with newly diagnosed metastatic prostate cancer initially treated with androgen deprivation therapy. (11th September 2019)

15. Characteristics of α2, 3‐sialyl N‐glycosylated PSA as a biomarker for clinically significant prostate cancer in men with elevated PSA level. Issue 16 (21st September 2021)

16. Clinical impact of early response to first‐line VEGFR‐TKI in patients with metastatic renal cell carcinoma on survival: A multi‐institutional retrospective study. (6th October 2022)

18. Clinical implications of serum N‐glycan profiling as a diagnostic and prognostic biomarker in germ‐cell tumors. (20th March 2017)

19. Clinical significance of the LacdiNAc‐glycosylated prostate‐specific antigen assay for prostate cancer detection. Issue 8 (27th June 2019)

20. Cohort profile: Alliance for Quality Assessment in Healthcare-Dialysis (AQuAH-D) prospective cohort study of patients on haemodialysis in Japan. Issue 1 (25th January 2022)